Kidswell Bio Corporation (TYO:4584)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015
Drug Development Business	6.59B	5.08B	1.57B	996.00M	1.08B
Drug Development Business Growth	29.67%	223.90%	57.53%	-7.52%	5.41%
Total	6.59B	5.08B	1.57B	996.00M	1.08B
Total Growth	29.67%	223.90%	57.53%	-7.52%	5.41%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015
Japan	6.59B	5.08B	1.57B	996.00M	1.08B
Japan Growth	29.67%	223.90%	57.53%	-7.52%	5.41%
Total	6.59B	5.08B	1.57B	996.00M	1.08B
Total Growth	29.67%	223.90%	57.53%	-7.52%	5.41%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error